3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
42
Lung Neoplasms
39
Leukemia, Myeloid, Acute
38
Carcinoma, Non-Small-Cell Lung
33
Neoplasm Metastasis
29
Breast Neoplasms
28
Myelodysplastic Syndromes
21
Lymphoma, Large B-Cell, Diffuse
20
Leukemia, Lymphocytic, Chronic, B-Cell
19
Colorectal Neoplasms
18
Pancreatic Neoplasms
17
Triple Negative Breast Neoplasms
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Multiple Myeloma
15
Ovarian Neoplasms
14
Glioblastoma
14
Carcinoma, Renal Cell
14
Squamous Cell Carcinoma of Head and Neck
13
Burkitt Lymphoma
13
Urinary Bladder Neoplasms
10
Mouth Neoplasms
10
Melanoma
10
Lymphoma, Mantle-Cell
10
Endometrial Neoplasms
10
Carcinoma, Hepatocellular
10
Carcinoma
10
Oropharyngeal Neoplasms
9
Leukemia, Myelomonocytic, Chronic
9
Laryngeal Neoplasms
9
Brain Neoplasms
9
Interventions
Specimen Handling
1
Physical Examination
1
Mastectomy, Subcutaneous
1
Mastectomy
1
Colonoscopy
1
Arsenic Trioxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Li-Fraumeni Syndrome
×
Specimen Handling
×
Clear all
NCT04541654
2026-03-27
LiFT_UP
Dana-Farber Cancer Institute
Recruiting
1,500 enrolled